Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mullan

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Bioorganic Chemistry|February 27, 2021
Novel, natural allosteric inhibitors and enhancers of Candida rugosa lipase activityAriane Menden, Stefan Crynen, Venkatarian Mathura, et al.
Journal of Neurotrauma|August 21, 2012
Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changesBenoit Mouzon, Helena Chaytow, Gogce Crynen, et al.
Brain Research|July 9, 2008
CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing miceVincent Laporte, Ghania Ait-Ghezala, Claude-Henry Volmar, et al.
Journal of Neurotrauma|November 29, 2016
Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain InjuryScott Ferguson, Benoit Mouzon, Daniel Paris, et al.
Bioinformation|July 9, 2011
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanismDaniel Paris, Venkat Mathura, Ghania Ait-Ghezala, et al.
Fluids and Barriers of the CNS|October 27, 2021
Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrierMaxwell Eisenbaum, Andrew Pearson, Arissa Gratkowski, et al.
Plos One|May 27, 2015
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADMegha Verma, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, et al.
The European Journal of Neuroscience|April 17, 2007
CD40 promotion of amyloid beta production occurs via the NF-kappaB pathwayGhania Ait-Ghezala, Claude-Henry Volmar, Jeremy Frieling, et al.
Plos One|August 1, 2015
Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADMegha Verma, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, et al.
International Journal of Alzheimer'S Disease|June 11, 2011
Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-AmyloidCheryl A Luis, Laila Abdullah, Ghania Ait-Ghezala, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Bioorganic Chemistry|February 27, 2021
Novel, natural allosteric inhibitors and enhancers of Candida rugosa lipase activityAriane Menden, Stefan Crynen, Venkatarian Mathura, et al.
Journal of Neurotrauma|August 21, 2012
Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changesBenoit Mouzon, Helena Chaytow, Gogce Crynen, et al.
Brain Research|July 9, 2008
CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing miceVincent Laporte, Ghania Ait-Ghezala, Claude-Henry Volmar, et al.
Journal of Neurotrauma|November 29, 2016
Acute or Delayed Treatment with Anatabine Improves Spatial Memory and Reduces Pathological Sequelae at Late Time-Points after Repetitive Mild Traumatic Brain InjuryScott Ferguson, Benoit Mouzon, Daniel Paris, et al.
Bioinformation|July 9, 2011
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanismDaniel Paris, Venkat Mathura, Ghania Ait-Ghezala, et al.
Fluids and Barriers of the CNS|October 27, 2021
Influence of traumatic brain injury on extracellular tau elimination at the blood-brain barrierMaxwell Eisenbaum, Andrew Pearson, Arissa Gratkowski, et al.
Plos One|May 27, 2015
Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADMegha Verma, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, et al.
The European Journal of Neuroscience|April 17, 2007
CD40 promotion of amyloid beta production occurs via the NF-kappaB pathwayGhania Ait-Ghezala, Claude-Henry Volmar, Jeremy Frieling, et al.
Plos One|August 1, 2015
Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of ADMegha Verma, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, et al.
International Journal of Alzheimer'S Disease|June 11, 2011
Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-AmyloidCheryl A Luis, Laila Abdullah, Ghania Ait-Ghezala, et al.
Pageof 15